QSS
GNMK

Quantitative Systematic Strategies’s GenMark Diagnostics, Inc GNMK Stock Holding History

Quantitative Systematic Strategies’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,120
Closed -$158K – 788
2020
Q3 		$158K Buy
+11,120
New +$170K 0.03% 543
2019
Q1 		– Sell
-23,947
Closed -$116K – 738
2018
Q4 		$116K Buy
+23,947
New +$125K 0.03% 598
2017
Q4 		– Sell
-17,621
Closed -$170K – 694
2017
Q3 		$170K Buy
17,621
+4,474
+34% +$46.5K 0.05% 411
2017
Q2 		$159K Buy
13,147
+2,047
+18% +$26.2K 0.04% 410
2017
Q1 		$142K Buy
+11,100
New +$134K 0.04% 340
2016
Q2 		– Sell
-35,260
Closed -$181K – 555
2016
Q1 		$181K Sell
35,260
-2,097
-6% -$11.7K 0.07% 252
2015
Q4 		$290K Sell
37,357
-11,272
-23% -$86.6K 0.08% 792
2015
Q3 		$383K Sell
48,629
-34,802
-42% -$322K 0.19% 234
2015
Q2 		$759K Buy
+83,431
New +$841K 0.17% 198

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantitative Systematic Strategies's GNMK Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 11,120 shares — an estimated $158K sold.

Quantitative Systematic Strategies first reported a position in GNMK in Q2 2015 and held it in 9 quarters. The position peaked at $759K in Q2 2015. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 11,120 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $158K.
  • Quantitative Systematic Strategies first reported a position in GenMark Diagnostics, Inc in Q2 2015 and held it in 9 quarters.
  • Quantitative Systematic Strategies's GenMark Diagnostics, Inc position peaked at $759K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.